TOBI (Tobramycin)
TOBI is indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa. Safety and efficacy have not been…
Medications Updated During June 2021, From Oldest to Newest, Page 74
Vancomycin (Vancomycin Hydrochloride)
Vancomycin Hydrochloride for Injection USP is indicated for the treatment of serious or severe infections caused by susceptible strains of methicillin-resistant (β-lactam-resistant)…
Citalopram Hydrobromide
Citalopram Oral Solution USP is indicated for the treatment of depression. The efficacy of Citalopram Oral Solution USP in the treatment of depression was established in 4 to 6 week,…
Lutathera (Lutetium Lu 177 Dotatate)
LUTATHERA is indicated for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut neuroendocrine…
Doxycycline Hyclate
To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline hyclate delayed-release tablets and other antibacterial drugs. Doxycycline hyclate…